Development and Validation of a Mutational Burden-Associated LncRNA Signature for Improving the Clinical Outcome of Hepatocellular Carcinoma.
Mingjun XuTing MaShanping ShiJingjun XingYang XiPublished in: Life (Basel, Switzerland) (2021)
This study identified a four-lncRNA signature (the MbLncSig score) which could predict survival in HCC patient with/without TP53 mutation.